Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂
Q1 2026 earnings • in 4 days
See details
PTCT:NASDAQ
PTC Therapeutics, Inc.
၆၅.၁၅ US$
+၀.၁၄%
(+၀.၀၉၀) 1D
၆၅.၁၅ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: မေ ၁, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTCT...
Open
၆၅.၀၈ US$
High
၆၇.၃၄ US$
Low
၆၃.၁၈ US$
Mkt. cap
၅၄၀.၁၇ ဋေ
Avg. vol.
၉.၉၀ သိန်း
Volume
၁.၃၂ သန်း
P/E ratio
၈.၃၇
52-wk high
၈၇.၅၀ US$
52-wk low
၃၅.၉၅ US$
EPS
၇.၇၈ US$
Beta
၀.၅၆
Shares outstanding
၈.၂၉ ကုဋေ
No. of employees
၉၉၁
News stories
From sources across the web
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၃ နာရီ
Hussman Strategic Advisors Inc. Has $1.91 Million Stake in PTC Therapeutics, Inc. $PTCT
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၀ နာရီ
PTC Therapeutics (PTCT) Reports Positive Huntington’s Disease Trial Results
Markets Mojo
Markets Mojo
·
ပြီးခဲ့သည့် ၂ ရက်
PTC Therapeutics Hits Day Low of $63.76 Amid Price Pressure
Profile
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
About PTC Therapeutics, Inc.
CEOMatthew B. Klein
Employees၉၉၁
Founded၁၉၉၈ ဇန် ၁
HeadquartersWarren, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteptcbio.com
Next call ၄ ရက်အတွင်း
မေ ၇ ကြာသပတေး, ၁၆:၃၀
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-၀.၄၄ est.)USD
Revenue / Estimate
-/ (၂၂.၅၃ ကုဋေ est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၁၁၇.၆၁ ဋေ
၁၇.၈၉ ကုဋေ
၂၁.၁၀ ကုဋေ
၁၆.၄၇ ကုဋေ
Cost of goods sold
၁၂.၁၈ ကုဋေ
၁၂.၄၄ ကုဋေ
၁၁.၅၉ ကုဋေ
၁၄.၀၁ ကုဋေ
Cost of revenue
၁၂.၁၈ ကုဋေ
၁၂.၄၄ ကုဋေ
၁၁.၅၉ ကုဋေ
၁၄.၀၁ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၁၀ ကုဋေ
၈.၅၃ ကုဋေ
၈.၄၀ ကုဋေ
၉.၆၉ ကုဋေ
Operating expense
၈.၄၈ ကုဋေ
၈.၉၃ ကုဋေ
၉.၁၆ ကုဋေ
၁၀.၆၂ ကုဋေ
Total operating expenses
၂၀.၆၆ ကုဋေ
၂၁.၃၇ ကုဋေ
၂၀.၇၅ ကုဋေ
၂၄.၆၃ ကုဋေ
Operating income
၉၆.၉၅ ကုဋေ
-၃.၄၉ ကုဋေ
၃.၄၉ သန်း
-၈.၁၆ ကုဋေ
Other non operating income
၂.၄၄ သန်း
၂.၉၆ သန်း
၁.၀၂ သိန်း
-၇.၆၅ သန်း
EBT including unusual items
၉၂.၉၈ ကုဋေ
-၇.၁၁ ကုဋေ
-၂.၃၁ ကုဋေ
-၁၃.၉၁ ကုဋေ
EBT excluding unusual items
၉၃.၁၅ ကုဋေ
-၇.၁၀ ကုဋေ
-၃.၁၄ ကုဋေ
-၁၅.၀၂ ကုဋေ
Income tax expense
၆.၃၃ ကုဋေ
-၆.၂၀ သန်း
-၃.၉၀ ကုဋေ
-၄.၁၂ သန်း
Effective tax rate
၆.၈၀%
၈.၇၃%
၁၆၈.၈၉%
၂.၉၆%
Other operating expenses
-
-
-
-
Net income
၈၆.၆၆ ကုဋေ
-၆.၄၈ ကုဋေ
၁.၅၉ ကုဋေ
-၁၃.၅၀ ကုဋေ
Net profit margin
၇၃.၆၈%
-၃၆.၂၅%
၇.၅၃%
-၈၁.၉၆%
Earnings per share
၁၀.၀၄
-၀.၈၃
၀.၁၉
-၁.၈၀
Interest and investment income
၁.၇၂ ကုဋေ
၂.၁၀ ကုဋေ
၁.၉၁ ကုဋေ
၂.၁၄ သန်း
Interest expense
-၅.၁၃ ကုဋေ
-၅.၁၃ ကုဋေ
-၅.၁၇ ကုဋေ
-၅.၇၃ ကုဋေ
Net interest expenses
-၃.၄၁ ကုဋေ
-၃.၀၄ ကုဋေ
-၃.၂၆ ကုဋေ
-၅.၅၂ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၉၇.၆၇ ကုဋေ
-၂.၇၃ ကုဋေ
၁.၄၆ ကုဋေ
-၆.၈၇ ကုဋေ
Gain or loss from assets sale
၇.၇၀ သောင်း
-
၅.၃၀ သောင်း
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more